BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7190300)

  • 1. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
    Bhargava HN
    Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New in vivo evidence for narcotic agonistic property of leucine-enkephalin.
    Bhargava HN
    J Pharm Sci; 1978 Jan; 67(1):136-7. PubMed ID: 563438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
    Székely JI; Miglécz E; Rónai AZ
    Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate-like action of methionine-enkephalin in inhibiting morphine abstinence syndrome.
    Bhargava HN
    Eur J Pharmacol; 1977 Jan; 41(1):81-4. PubMed ID: 556692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral activating effects of opiates and opioid peptides.
    Browne RG; Segal DS
    Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intracerebroventricular infusion of morphine, methionine-enkephalin and D-Ala2-enkephalinamide on body temperature of rabbits.
    Konecka AM; Sadowski B; Jaszczak J; Panocka I; Sroczynska I; Misicka A
    Arch Int Physiol Biochim; 1982 Apr; 90(1):1-7. PubMed ID: 6179485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
    Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraventricular morphine and enkephalins on locomotor activity in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Sep; 218(3):613-20. PubMed ID: 7021799
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
    Ueda H; Amano H; Shiomi H; Takagi H
    Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
    Bhargava HN; Matwyshyn GA
    Psychopharmacology (Berl); 1985; 87(2):141-6. PubMed ID: 2996045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence.
    Vaught JL; Takemori AE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):86-90. PubMed ID: 569699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-Thr2, Thz5]-enkephalinamide: a potent analgesic by subcutaneous and oral administration.
    Tseng LF; Loh HH; Li CH
    Life Sci; 1978 Nov; 23(20):2053-6. PubMed ID: 569237
    [No Abstract]   [Full Text] [Related]  

  • 19. D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.
    Tortella FC; Moreton JE
    Psychopharmacology (Berl); 1980; 69(2):143-7. PubMed ID: 6779307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peptidase inhibitors, [D-Ala2, Met5]-enkephalinamide and antiserum to methionine-enkephalin microinjected into the caudal periaqueductal gray on morphine withdrawal in rats.
    Fukunaga Y; Inoue N; Miyamoto M; Kishioka S; Yamamoto H
    Jpn J Pharmacol; 1998 Dec; 78(4):455-61. PubMed ID: 9920202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.